Chemoinformaics analysis of (2S,3R,4S,5R)-3,4,5,6-TETRAHYDROXYOXANE-2-CARBOXYLIC ACID
| Molecular Weight | 194.139 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.059 | nRig | 6 |
| Exact Molecular Weight | 194.043 | nRing | 1 |
| Solubility: LogS | -4.673 | nHRing | 1 |
| Solubility: LogP | 4.724 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 22.3019 |
| nHD | 5 | BPOL | 12.6361 |
| QED | 0.536 |
| Synth | 3.124 |
| Natural Product Likeliness | 2.4 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.564 |
| MDCK | 0.0000252 |
| BBB | 0.719 |
| PPB | 0.962231 |
| VDSS | 3.208 |
| FU | 0.0330476 |
| CYP1A2-inh | 0.745 |
| CYP1A2-sub | 0.851 |
| CYP2c19-inh | 0.455 |
| CYP2c19-sub | 0.894 |
| CYP2c9-inh | 0.202 |
| CYP2c9-sub | 0.604 |
| CYP2d6-inh | 0.511 |
| CYP2d6-sub | 0.887 |
| CYP3a4-inh | 0.483 |
| CYP3a4-sub | 0.377 |
| CL | 7.658 |
| T12 | 0.303 |
| hERG | 0.079 |
| Ames | 0.112 |
| ROA | 0.216 |
| SkinSen | 0.973 |
| Carcinogencity | 0.489 |
| EI | 0.981 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.042 |
| Antiviral | No |
| Prediction | 0.885648 |